[1,1':4',1'':4'',1'''-quaterphenyl]-4,4'''-dicarbaldehyde, 97%, 250mg

1-(4-(1,3-Dioxolan-2-yl)-3-fluorophenyl)-4-methylpiperazine, 98%, 5g

5-tert-Butyl-2-(3-methyl-benzyl)-2H-pyrazole-3-carboxylic acid hydrazide, 95%+, 250mg

2-([1,1':3',1''-Terphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

2-(Benzylamino)acetonitrile, 95.0%, 5g

4-(Bromomethyl)phenyl acetate, 95.0%, 100mg

TIPS-5-Ethynyl-dU-CEP, ≥90%, 1 g, confezione in plastica.

N,N'-Diphenyl-N,N'-bis[4'-(diphenylamino)biphenyl-4-yl]benzidine>98.0%(HPLC)(N)5g

Oxazolidine-2,5-dione, 95.0%, 1g

Ethyl 2-(2,5-dichlorophenyl)sulfanylacetate, 5g

(4-Chloro-phenyl)-[4-(3-chloro-5-trifluoromethyl-pyridin-2-ylmethyl)-piperazin-1-yl]-methanone, 95.0%, 100mg

DARAPLADIB, 95%, 50mg

N-(3-Fluoro-4-methylphenyl)-4-methylbenzenesulfonamide, 95%, 250mg